- Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study?
- Is your viral load suppressed/undetectable?
- Are you able to receive a vaccine?
- Are you generally healthy?
- Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.
Unlock the power of effective email communication
Learn 5 steps to writing emails that work in this 30-minute session at 11 a.m. July 15. Register now.
UAB and Birmingham Promise: a partnership for the future
Annual performance evaluation cycle opens July 1
3 chosen as UAB VIPs for second-quarter 2024
John Huffstutler, Nancy Parsons and Angel Simmons are the second-quarter 2024 honorees of the UAB Values in Action Program. Nominations for third-quarter 2024 honorees are open through July 11.